RadNet (RDNT) Projected to Post Quarterly Earnings on Sunday

Key Points

• RadNet is set to report its Q2 2025 earnings on August 10th, with analysts projecting earnings of $0.17 per share and revenue of $488.06 million.
• The company's stock price has faced fluctuations, recently opening at $54.69 with a market capitalization of $4.10 billion despite a 12-month high of $93.65.
• Insider trading activity has been notable, with COO Norman R. Hames and EVP Alma Gregory Sorensen selling significant shares, representing decreases in their ownership of RadNet stock.

RadNet (NASDAQ:RDNT - Get Free Report) is expected to issue its Q2 2025 quarterly earnings data after the market closes on Sunday, August 10th. Analysts expect the company to announce earnings of $0.17 per share and revenue of $488.06 million for the quarter.

RadNet Stock Down 0.1%

RDNT stock opened at $54.69 on Friday. The firm's fifty day simple moving average is $56.81 and its 200-day simple moving average is $56.09. The company has a market capitalization of $4.10 billion, a P/E ratio of -127.18 and a beta of 1.43. The company has a debt-to-equity ratio of 0.87, a current ratio of 2.01 and a quick ratio of 2.01. RadNet has a 12 month low of $45.00 and a 12 month high of $93.65.

Insider Activity at RadNet

In other RadNet news, COO Norman R. Hames sold 2,911 shares of the firm's stock in a transaction that occurred on Thursday, May 15th. The shares were sold at an average price of $60.00, for a total transaction of $174,660.00. Following the sale, the chief operating officer owned 24,889 shares of the company's stock, valued at approximately $1,493,340. This trade represents a 10.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Alma Gregory Sorensen sold 55,000 shares of RadNet stock in a transaction on Friday, May 23rd. The shares were sold at an average price of $56.48, for a total transaction of $3,106,400.00. Following the completion of the transaction, the executive vice president directly owned 1,160,509 shares in the company, valued at $65,545,548.32. The trade was a 4.52% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 63,447 shares of company stock worth $3,613,220. 5.60% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On RadNet

Institutional investors have recently modified their holdings of the business. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in RadNet by 2.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 440,543 shares of the medical research company's stock valued at $21,904,000 after buying an additional 8,762 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in RadNet by 4.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 39,341 shares of the medical research company's stock valued at $1,956,000 after buying an additional 1,699 shares during the last quarter. AQR Capital Management LLC grew its position in RadNet by 5.4% in the 1st quarter. AQR Capital Management LLC now owns 6,846 shares of the medical research company's stock valued at $340,000 after buying an additional 350 shares during the last quarter. United Services Automobile Association purchased a new position in RadNet in the 1st quarter valued at $216,000. Finally, Strs Ohio purchased a new position in RadNet in the 1st quarter valued at $139,000. 77.90% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on RDNT. Truist Financial set a $74.00 price target on shares of RadNet in a report on Thursday, July 10th. Wall Street Zen cut shares of RadNet from a "hold" rating to a "sell" rating in a research report on Sunday, June 29th. Finally, B. Riley began coverage on shares of RadNet in a research report on Friday, June 13th. They set a "buy" rating and a $69.00 price objective for the company. One analyst has rated the stock with a sell rating, three have issued a buy rating and three have assigned a strong buy rating to the company. According to MarketBeat, RadNet presently has an average rating of "Buy" and a consensus target price of $69.60.

About RadNet

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.